Skip to main content

Taking ATMPs to Market

The Cell and Gene Therapy Catapult (CGT Catapult) is an independent not-for-profit innovation and technology organisation committed to the advancement of cell and gene therapies. 

Learn about the presentation on 'Taking Advanced Therapy Medicinal Products (ATMPs) to Market' produced by CGT Catapult. The presentation slides are available as a PDF to download or view online.

Within the slides you will find information on:

  • The regulatory framework in EU
  • Therapy classification and case studies 
  • Early development support by EMA (EU) and MHRA (UK)
  • Pathways for market access in Europe, USA, and Japan
CGT Catapult: Taking ATMPs to Market

CGT Catapult's presentation on 'Taking Advanced Therapy Medicinal Products (ATMPs) to Market'

Note: This resource was created pre-BREXIT. For post-BREXIT guidance in the UK context, please see this page.

 

¿Le pareció útil el contenido de esta página? Envianos tus comentarios
-
Your feedback helps us keep EuroGCT online. Please can you take 30 seconds to answer these quick questions?
How would you rate your experience using EuroGCT.org today?
Poor
Great
Is the information on this website understandable?
Not at all understandable
Very understandable
Is the information on this website useful?
Not at all useful
Very useful
Is the website easy to use and navigate?
Not at all easy
Very easy
Why are you interested in gene and cell therapies and research?
CAPTCHA
Esta pregunta es para comprobar si usted es un visitante humano y prevenir envíos de spam automatizado.